Research study Program year 2024 Source: CMS Open Payments

Gantenerumab Open Label Extension

Research payments

$708,656

151 payments

Through program year 2024, $708,656 in research payments was reported against Gantenerumab Open Label Extension, across 151 payments, paid by Genentech, Inc..

Paid by: Genentech, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

5 rows

Year	Kind	Amount	Payments
2024	Research	$15,559	2
2023	Research	$92,296	22
2022	Research	$322,470	71
2021	Research	$244,081	52
2020	Research	$34,250	4

Breakdown

Who paid Research payments · program years 2020–2024

Genentech, Inc. $708,656 151 payments

Who received the money Research payments · program years 2020–2024

Senior Adults Specialty Research PA Organisation paid for research $126,157 10 payments
Compass Research LLC Organisation paid for research $117,845 29 payments
Central States Research LLC Organisation paid for research $83,160 13 payments
Banner Health Organisation paid for research $67,192 9 payments
Amc Research LLC Mohammad Reza Bolouri MD Organisation paid for research $37,660 9 payments
University of South Florida Board of Trustees Organisation paid for research $34,812 13 payments
Neurology Clinic Pc MD Organisation paid for research $26,439 4 payments
Neurology Clinic Pc Organisation paid for research $26,318 5 payments
Thomas M Shiovitz MD INC California Neuroscience Research Medical Group INC Organisation paid for research $22,296 9 payments
Medical Group INC Organisation paid for research $21,288 8 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

8 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.